Australian Clinical Labs Ltd (AU:ACL) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Citigroup Global Markets Australia Pty Limited and its associated entities have ceased to be substantial holders in Australian Clinical Labs Ltd as of 17 September 2024, reducing their voting power by a significant number of shares via securities lending agreements and ordinary stock market transactions. This marks a change in the shareholding structure of the company, potentially impacting investor relations and stock market performance.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.